SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-24-000052
Filing Date
2024-01-04
Accepted
2024-01-04 16:00:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 TO THE SCHEDULE 13D sc13da709050032_01032024.htm SC 13D/A 227375
  Complete submission text file 0000921895-24-000052.txt   229025
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Subject) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: SC 13D/A | Act: 34 | File No.: 005-45181 | Film No.: 24511686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 12121 WILSHIRE BLVD., SUITE 1240 LOS ANGELES CA 90025
Business Address 12121 WILSHIRE BLVD., SUITE 1240 LOS ANGELES CA 90025 424-253-1774
Legion Partners Asset Management, LLC (Filed by) CIK: 0001560207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A